With Interchangeability Nod, Viatris' Semglee Loses Its Identity

 
• By Sue Sutter
The US FDA's first-ever interchangeable designation opens new roads for biosimilars. • Source: Nielsen Hobbs

More from Biosimilars

More from Biosimilars & Generics